IL92587A0 - 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition - Google Patents

2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition

Info

Publication number
IL92587A0
IL92587A0 IL92587A IL9258789A IL92587A0 IL 92587 A0 IL92587 A0 IL 92587A0 IL 92587 A IL92587 A IL 92587A IL 9258789 A IL9258789 A IL 9258789A IL 92587 A0 IL92587 A0 IL 92587A0
Authority
IL
Israel
Prior art keywords
nucleoside
composition
combination therapy
dideoxypurine
inhibitor combination
Prior art date
Application number
IL92587A
Other versions
IL92587A (en
Original Assignee
Ciba Geigy Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ciba Geigy Ag filed Critical Ciba Geigy Ag
Publication of IL92587A0 publication Critical patent/IL92587A0/en
Publication of IL92587A publication Critical patent/IL92587A/en

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/70—Carbohydrates; Sugars; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/12—Antivirals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Molecular Biology (AREA)
  • Virology (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
IL9258789A 1988-12-14 1989-12-07 Compositions containing 2', 3'-dideoxypurine nucleoside and a purine nucleoside phosphorylase inhibitor for the treatment of retrovirus infections IL92587A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US28415388A 1988-12-14 1988-12-14
US31535489A 1989-02-24 1989-02-24

Publications (2)

Publication Number Publication Date
IL92587A0 true IL92587A0 (en) 1990-08-31
IL92587A IL92587A (en) 1994-04-12

Family

ID=26962435

Family Applications (1)

Application Number Title Priority Date Filing Date
IL9258789A IL92587A (en) 1988-12-14 1989-12-07 Compositions containing 2', 3'-dideoxypurine nucleoside and a purine nucleoside phosphorylase inhibitor for the treatment of retrovirus infections

Country Status (10)

Country Link
EP (1) EP0374096B1 (en)
JP (1) JPH02204414A (en)
KR (1) KR900009083A (en)
AU (1) AU628113B2 (en)
CA (1) CA2005205A1 (en)
DE (1) DE58902899D1 (en)
DK (1) DK630589A (en)
IE (1) IE893991L (en)
IL (1) IL92587A (en)
NZ (1) NZ231718A (en)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ229453A (en) * 1988-06-10 1991-08-27 Univ Minnesota & Southern Rese A pharmaceutical composition containing purine derivatives with nucleosides such as azt, as antiviral agents
JP2619710B2 (en) * 1989-02-27 1997-06-11 日本製紙 株式会社 Method for producing 2 ', 3'-dideoxypurine nucleosides
JP2760364B2 (en) * 1989-02-27 1998-05-28 バイオクライシス・ファーマシューティカルズ、インコーポレイテッド 9-substituted-8-unsubstituted-9-deazaguanines
DE69116750T2 (en) * 1990-07-04 1996-11-14 Merrell Dow Pharma 9-purinyl-phosphonic acid derivatives
WO1992020344A1 (en) * 1991-05-16 1992-11-26 Glaxo Group Limited Antiviral combinations containing nucleoside analogs
US5494912A (en) * 1991-06-26 1996-02-27 Merrell Pharmaceuticals Inc. 9-purinyl phosphonic acid derivitives for treating gout
CZ27399A3 (en) * 1999-01-26 2000-08-16 Ústav Experimentální Botaniky Av Čr Substituted nitrogen heterocyclic derivatives process of their preparation, the derivatives employed as medicaments, pharmaceutical composition and a compound pharmaceutical preparation in which these derivatives are comprised as well as use of these derivatives for preparing medicaments
MXPA06002001A (en) * 2003-08-26 2006-06-20 Teijin Pharma Ltd Pyrrolopyrimidinone derivative.
US7557113B2 (en) 2003-08-26 2009-07-07 Teijin Pharma Limited Substituted pyrrolo[3,2-d]pyrimidine derivatives
DE102006017600A1 (en) * 2006-02-09 2007-08-16 Friedel, Ruthard, Dr. Use of nucleoside analogues such as purine derivatives, as medicines against viruses and cytostatic against cancer, where the nucleoside analogue has a donor group, acceptor group, and pairs only with natural base thymine
US9452217B2 (en) * 2013-06-22 2016-09-27 Nitor Therapeutics Methods for potentiating immune response for the treatment of infectious diseases and cancer
WO2018045045A1 (en) 2016-08-30 2018-03-08 University Of Pittsburgh - Of The Commonwealth System Of Higher Education Methods for treatment using small molecule potassium-sparing diuretics and natriuretics
GB201820098D0 (en) * 2018-12-10 2019-01-23 Cambridge Entpr Ltd Methods of cancer treatment

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JPS60126220A (en) * 1983-12-09 1985-07-05 Otsuka Pharmaceut Factory Inc Nucleic acid component composition
AU570853B2 (en) * 1985-08-26 1988-03-24 United States of America, as represented by the Secretary, U.S. Department of Commerce, The Inhibition of infectivity and cytopathic effect of htlv-111/ lav by purine bases

Also Published As

Publication number Publication date
EP0374096B1 (en) 1992-12-02
AU628113B2 (en) 1992-09-10
CA2005205A1 (en) 1990-06-14
IL92587A (en) 1994-04-12
NZ231718A (en) 1992-02-25
DK630589D0 (en) 1989-12-13
EP0374096A1 (en) 1990-06-20
IE893991L (en) 1990-06-14
DK630589A (en) 1990-06-15
AU4607489A (en) 1990-06-21
DE58902899D1 (en) 1993-01-14
JPH02204414A (en) 1990-08-14
KR900009083A (en) 1990-07-02

Similar Documents

Publication Publication Date Title
CY2018A (en) Therapeutic nucleosides
AU589371B2 (en) Purine derivatives and use as therapeutic agent
GB2221390B (en) Niacin-containing composition and its therapeutic use
ZA9010365B (en) Therapeutic nucleosides
ZA89440B (en) Dideoxydidehydrocarbocyclic nucleosides
GB8901187D0 (en) Dideoxydidehydrocarbocyclic nucleosides
HU00045A9 (en) Novel 2'-halomethylidene, 2'-ethenylidene and 2'-ethynyl cytidine-, uridine and guanosine derivatives
IL92587A0 (en) 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition
IL91773A0 (en) 2'haloethylidene,2'-ethenylidene and 2'-ethynyl adenosine derivatives
HU9201450D0 (en) Inhibitors of purine nucleoside phosphorylase
GB8911294D0 (en) Composition and use
EP0356166A3 (en) Therapeutic nucleosides
ZA899510B (en) 2',3'-dideoxypurine nucleoside/purine nucleoside phosphorylase inhibitor combination therapy and composition
GB8823353D0 (en) Therapeutic nucleosides
GB9110987D0 (en) Dideoxydidehydrocarboxyclic nucleosides
ZA897257B (en) Novel 2'-halomethylidene,2'-ethenylidene and 2'-ethynyl adenosine derivatives
IE881047L (en) Therapeutic nucleosides
GB8824899D0 (en) Therapeutic nucleosides
ZA896328B (en) Therapeutic nucleosides
IE880748L (en) Therapeutic nucleosides
GB8816284D0 (en) Therapeutic nucleosides
IE893701L (en) 2'-deoxy-4'-azido-substituted nucleosides
ZA907877B (en) Therapeutic nucleosides
GB8901294D0 (en) Therapeutic nucleosides
IE883323L (en) Therapeutic nucleoside analogues

Legal Events

Date Code Title Description
KB Patent renewed